Pharmaceutical care (PKD 86.99.A)
This subclass includes activities related to pharmaceutical care, being a health service provided by a pharmacist and constituting a documented process. The pharmacist, in cooperation with the patient and the physician treating the patient, and where necessary with representatives of other medical activities, oversees the proper course of individual pharmacotherapy. This activity includes, among others:
- carrying out medication reviews together with an assessment of pharmacotherapy,
- developing an individual pharmaceutical care plan.
Industry statistics (2025)
Number of companies
Companies
1,506
Companies (primary PKD)
105
Companies with financials
2
Business turnover
Stock market
No companies from this industry are listed.
Related PKD codes in division 86
FAQ
The primary industry for 105 companies is pharmaceutical care. 2 entities have filed financial statements.
So far in 2026, 18 new companies with PKD 86.99.A have been registered. In all of 2025, there were 29 such companies.
So far in 2026, 2 companies with PKD 86.99.A have been deregistered.
In 2025, the median revenue for PKD 86.99.A was USD 63.93k and the mean revenue was USD 63.93k, based on 2 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
Yes, in 2025, the median net profit was USD 14.93k.